PHARMACY

FDA gives Celltrion, Teva green light for biosimilar Herceptin
The Food and Drug Administration has approved Celltrion and Teva’s biosimilar to Herceptin, Herzuma (trastruzumab-pkrb).
NACDS reacts to Texas Federal District Court’s ruling to strike down ACA
NACDS vows additional advocacy efforts in light of Texas federal district court ruling to strike down the ACA.

FDA gives nod, tentative OK for Lupin's 2 generics

Lupin has received the Food and Drug Administration's OK for generic Onfi, and tentative nod for generic Adcirca, with a value of $601.2 million and $503.8 million, respectively.
Emerson Group, MarketHub ink CBD-focused partnership

The companies’ partnership is aimed at offering retailers and customers a seamless entry point into the CBD industry.
Mylan launches generic Lialda

The Food and Drug Administration has approved Mylan's generic Lialda, which had a market value of roughly $842 million for the year ended Oct. 31, according to IQVIA data.
Vitruvius Therapeutics gets FDA nod for generic Amicar

Vitruvius recently received the FDA's approval for generic Amicar, which has a market value of roughly $26.2 million.
CRN: Farm Bill offers promise for hemp, lacks VMS SNAP measure

Pleased that the Farm Bill includes the Hemp Farming Act, the Council for Responsible Nutrition noted its disappointment that it omits the SNAP Vitamin and Supplements Improvement Act.
Study: Social determinants of health contribute to hypertension

A new study from higi found that hypertension is associated with the social determinants of health.
NACDS grant partners increase adult vaccination awareness

NACDS' grant partners have published articles in the journal Vaccine, outlining the results of projects designed to increase adult vaccination.
Hy-Vee buys files from 22 Shopko pharmacies

Shopko patient files will merge into existing Hy-Vee Pharmacy locations in the 17 cities where the acquisitions have taken place.